FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149771835> ?p ?o ?g. }

• W2149771835 endingPage "1235" @default.
• W2149771835 startingPage "1226" @default.
• W2149771835 abstract "OBJECTIVE: To evaluate the microbiology, pharmacokinetic parameters, drug interactions, and results of the available clinical trials of gemifloxacin for the treatment of community-acquired pneumonia (CAP) and acute exacerbation of chronic bronchitis (AECB). DATA SOURCES: MEDLINE (1966–September 2003) was searched for primary and review articles. Data from the manufacturer were also included. Key words included adverse effects, clinical trials, drug interactions, gemifloxacin, and pharmacokinetic parameters. STUDY SELECTION AND DATA EXTRACTION: All articles and product labeling concerning gemifloxacin, a fluoroquinolone antibiotic recently approved by the Food and Drug Administration for treatment of CAP and AECB, were included for review. DATA SYNTHESIS: Compared with currently available fluoroquinolones, gemifloxacin demonstrated improved in vitro activity against Streptococcus pneumoniae (minimum inhibitory concentration for 90% eradication 0.03 μg/mL) and similar activity against gram-negative respiratory pathogens ( Haemophilus influenzae, Moraxella catarrhalis) and atypical pathogens such as Chlamydia pneumoniae, Legionella pneumophila, and Mycoplasma pneumoniae. Gemifloxacin, consistent with other available fluoroquinolones, has insufficient activity against methicillin-resistant Staphylococcus aureus to allow clinical use for such infections. Gemifloxacin has adequate bioavailability and a favorable drug interaction profile. Gemifloxacin was comparable to commonly employed nonfluoroquinolone regimens for treatment of CAP and AECB, although the studies were designed to demonstrate equivalence. Gemifloxacin once daily for 5–7 days was well tolerated in controlled and uncontrolled clinical studies. Available clinical data, however, are insufficient to draw clinical or toxicologic distinctions between gemifloxacin and other fluoroquinolones. CONCLUSIONS: Gemifloxacin may be a suitable choice for empiric treatment of CAP or AECB. However, due to the significant history of fluoroquinolone-induced hepatic failure and dermatologic complications, the use of this drug should be closely monitored." @default.
• W2149771835 created "2016-06-24" @default.
• W2149771835 creator A5003250918 @default.
• W2149771835 creator A5007825238 @default.
• W2149771835 creator A5084249121 @default.
• W2149771835 creator A5085827309 @default.
• W2149771835 date "2004-07-01" @default.
• W2149771835 modified "2023-09-26" @default.
• W2149771835 title "Gemifloxacin: A New Fluoroquinolone Approved for Treatment of Respiratory Infections" @default.
• W2149771835 cites W1513321454 @default.
• W2149771835 cites W1571594650 @default.
• W2149771835 cites W1866015860 @default.
• W2149771835 cites W1966311769 @default.
• W2149771835 cites W1971799109 @default.
• W2149771835 cites W1982607879 @default.
• W2149771835 cites W1997998566 @default.
• W2149771835 cites W2004522996 @default.
• W2149771835 cites W2005265212 @default.
• W2149771835 cites W2009639913 @default.
• W2149771835 cites W2015183755 @default.
• W2149771835 cites W2020021497 @default.
• W2149771835 cites W2024200878 @default.
• W2149771835 cites W2036838340 @default.
• W2149771835 cites W2038645755 @default.
• W2149771835 cites W2040172715 @default.
• W2149771835 cites W2048809652 @default.
• W2149771835 cites W2064876709 @default.
• W2149771835 cites W2066432484 @default.
• W2149771835 cites W2073553604 @default.
• W2149771835 cites W2075738790 @default.
• W2149771835 cites W2082196228 @default.
• W2149771835 cites W2092873084 @default.
• W2149771835 cites W2094604496 @default.
• W2149771835 cites W2097667778 @default.
• W2149771835 cites W2099491124 @default.
• W2149771835 cites W2099650842 @default.
• W2149771835 cites W2099867105 @default.
• W2149771835 cites W2100418869 @default.
• W2149771835 cites W2103144573 @default.
• W2149771835 cites W2103395799 @default.
• W2149771835 cites W2103785777 @default.
• W2149771835 cites W2105429017 @default.
• W2149771835 cites W2108570467 @default.
• W2149771835 cites W2109226805 @default.
• W2149771835 cites W2109910846 @default.
• W2149771835 cites W2110936661 @default.
• W2149771835 cites W2112208431 @default.
• W2149771835 cites W2114535764 @default.
• W2149771835 cites W2116630166 @default.
• W2149771835 cites W2118681240 @default.
• W2149771835 cites W2126245069 @default.
• W2149771835 cites W2126488027 @default.
• W2149771835 cites W2128682961 @default.
• W2149771835 cites W2129790135 @default.
• W2149771835 cites W2136848060 @default.
• W2149771835 cites W2140778402 @default.
• W2149771835 cites W2142324340 @default.
• W2149771835 cites W2143071359 @default.
• W2149771835 cites W2146831409 @default.
• W2149771835 cites W2146904342 @default.
• W2149771835 cites W2149562987 @default.
• W2149771835 cites W2152147427 @default.
• W2149771835 cites W2152166532 @default.
• W2149771835 cites W2152318217 @default.
• W2149771835 cites W2153978739 @default.
• W2149771835 cites W2161981311 @default.
• W2149771835 cites W2162820764 @default.
• W2149771835 cites W2164297234 @default.
• W2149771835 cites W2166641769 @default.
• W2149771835 cites W3191029413 @default.
• W2149771835 cites W4211003030 @default.
• W2149771835 cites W4233875887 @default.
• W2149771835 cites W4236530034 @default.
• W2149771835 cites W82875543 @default.
• W2149771835 doi "https://doi.org/10.1345/aph.1e003" @default.
• W2149771835 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15187209" @default.
• W2149771835 hasPublicationYear "2004" @default.
• W2149771835 type Work @default.
• W2149771835 sameAs 2149771835 @default.
• W2149771835 citedByCount "42" @default.
• W2149771835 countsByYear W21497718352012 @default.
• W2149771835 countsByYear W21497718352013 @default.
• W2149771835 countsByYear W21497718352015 @default.
• W2149771835 countsByYear W21497718352016 @default.
• W2149771835 countsByYear W21497718352019 @default.
• W2149771835 countsByYear W21497718352020 @default.
• W2149771835 countsByYear W21497718352021 @default.
• W2149771835 countsByYear W21497718352022 @default.
• W2149771835 countsByYear W21497718352023 @default.
• W2149771835 crossrefType "journal-article" @default.
• W2149771835 hasAuthorship W2149771835A5003250918 @default.
• W2149771835 hasAuthorship W2149771835A5007825238 @default.
• W2149771835 hasAuthorship W2149771835A5084249121 @default.
• W2149771835 hasAuthorship W2149771835A5085827309 @default.
• W2149771835 hasConcept C126322002 @default.
• W2149771835 hasConcept C2776012195 @default.
• W2149771835 hasConcept C2776088887 @default.
• W2149771835 hasConcept C2776551000 @default.

• next